Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
621
-
Total 13F shares, excl. options
-
68,591,681
-
Shares change
-
-1,580,502
-
Total reported value, excl. options
-
$16,905,826,463
-
Value change
-
-$426,987,902
-
Put/Call ratio
-
49%
-
Number of buys
-
305
-
Number of sells
-
-302
-
Price
-
$246.08
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2022
716 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2022.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 621 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68,591,681 shares
of 71,941,794 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,925,965 shares), BlackRock Inc. (8,090,611 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,870,122 shares), STATE STREET CORP (3,331,274 shares), FRANKLIN RESOURCES INC (2,654,111 shares), APG Asset Management N.V. (2,317,470 shares), FMR LLC (1,981,083 shares), Bank of New York Mellon Corp (1,742,486 shares), T. Rowe Price Investment Management, Inc. (1,707,744 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,469,889 shares).
This table shows the top 621 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.